Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780531 · ClinicalTrials.gov registry record
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
A clinical trial of Neurological Disorders and Neuromuscular Disorders, sponsored by St. Louis University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02780531: Completed study of Neurological Disorders and Neuromuscular Disorders, sponsored by St. Louis University.
NCT02780531 is a study of Neurological Disorders and Neuromuscular Disorders that has completed, run by St. Louis University. The registered enrollment target is 20 participants, below the 33,532-participant average among 3 other Neurological Disorders trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02780531, a study of Neurological Disorders and Neuromuscular Disorders, has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genetic or other factors in the subjects blood that may predispose them to getting a particular disease or tell researchers how the disease will behave, for example how fast it will progress or what areas of the body might be affected. A second goal is to relate such factors to how such a condition affects the subjects clinically as well as how it affects the electrical functions of nerves and muscles.
Primary Outcome
Genetic test by collection of blood including whole exome sequencing and targeted gene sequencing
Conditions Studied
Study Locations (1)
Missouri
- Saint Louis University Department of Neurology - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-10-17 |
What the finished NCT02780531 record still lists
NCT02780531 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 33,532-participant average among 3 other Neurological Disorders trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Neurological Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT02780531 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02780531 about?
NCT02780531 is a clinical study titled "Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases". The purpose of this study is to identify genetic or other factors in the subjects blood that may predispose them to getting a particular disease or tell researchers how the disease will behave, for example how fast it will progress or what areas of the body might be affected. A second goal is to rel...
What is the current status of trial NCT02780531?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-12. Estimated completion is 2018-10-17.
What conditions does trial NCT02780531 study?
This clinical trial studies the following conditions: Neurological Disorders, Neuromuscular Disorders.
Who is sponsoring clinical trial NCT02780531?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02780531 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurological Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia